Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 812-038-2 | CAS number: 1192651-80-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21 October 2005 - 09 November 2005
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- This Ames study was performed in accordance with guidelines and GLP principles, however no E.coli strain was included.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- (21 July 1997)
- Deviations:
- yes
- Remarks:
- (No E.coli strain included)
- Qualifier:
- according to guideline
- Guideline:
- other: ICH Harmonised Tripartite Guideline (including recommendations for adoption at Step 4 of the ICH Process on 19 July 1995 and 16 July 1997 by the ICH Steering Committee).
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- dd. 09 May 2005
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- NXL 104
- IUPAC Name:
- NXL 104
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material (as cited in study report): NXL104
- Substance type: Organic
- Physical state: Almost white crystalline powder
- Expiration date of the batch: July 2006
- Storage condition of test material: at +4°C and protected from humidity
Constituent 1
Method
- Target gene:
- Histidine gene
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix obtained from the liver of rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- Preliminary test: 10, 100, 500, 1000, 2500 and 5000 µg/plate;
Main experiment 1: 0.78, 1.56, 3.13, 6.25, 12.5, 25 µg/plate (TA100, TA 1535, with and without S9-mix); 1.56, 3.13, 6.25, 12.5, 25, 50 µg/plate (TA98, TA 1537and TA102, without S9-mix); 1.56, 3.13, 6.25, 12.5, 25, 50 µg/plate (TA98, TA 1537, with S9-mix); 3.13, 6.25, 12.5, 25, 50, 100 µg/plate (TA102, with S9-mix)
Main experiment 2: 1.56, 3.13, 6.25, 12.5, 25, 50 µg/plate (TA98, TA100, TA1535, TA1537, with S9-mix); 3.13, 6.25, 12.5, 25, 50 µg/plate (TA102, with S9-mix) - Vehicle / solvent:
- - Vehicle used: water (the test item was freely soluble in water at 50 mg/mL.).
Controlsopen allclose all
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Remarks:
- NAN3 at 1 µg/plate (TA 1535 and TA 100); 9AA at 50 µg/plate (TA1537); 2NF at 0.5 µg/plate (TA98); MMC at 0.5 µg/plate (TA 102).
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- mitomycin C
- Remarks:
- Without S9 mix
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Remarks:
- at 2 µg/plate (TA1535, TA 1537, TA 98, TA 100); at 10 µg/plate (TA102)
- Positive control substance:
- other: 2-Anthramine (2AM)
- Remarks:
- With S9 mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: direct plate incorporation method (preliminary test, both experiments without S9 mix and the first experiment with S9 mix ) and preincubation method (experiment with S9 mix).
All the concentrations and dose-levels were expressed as active item taking into account the declared content of 86.44%. - Evaluation criteria:
- The study was considered valid if the following criteria were fully met:
- the number of revertants in the vehicle controls was consistent with the historical data of the testing facility,
- the number of revertants in the positive controls was higher than that of the vehicle controls and consistent with the historical data of the testing facility.
A reproducible 2-fold increase (for the TA 98, TA 100 and TA 102 strains) or 3-fold increase (for the TA 1535 and TA 1537 strains) in the number of revertants compared with the vehicle controls, in any strain at any dose-level and/or evidence of a dose-relationship was considered as a positive result. Reference to historical data, or other considerations of biological relevance may also be taken into account in the evaluation of the data obtained.
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Cytotoxicity was seen without S9 mix at ≥ 50 μg/plate and in presence of S9-mix at ≥ 25 μg/plate (except for TA102: at ≥ 50 μg/plate).
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No precipitation was observed at any dose level.
RANGE-FINDING/SCREENING STUDIES:
The test item was strongly toxic at dose-levels ≥100 μg/plate in the three tested strains (TA98, TA100 and TA102), with and without S9 mix.
COMPARISON WITH HISTORICAL CONTROL DATA:
The number of revertants for the vehicle and positive controls was as specified in the acceptance criteria. The study was therefore considered valid.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
A slight to marked toxicity (decrease in the number of revertants) was noted in the tester strains generally at 50 μg/plate in absence of S9 mix. In presence of S9-mix, a slight to marked toxicity was noted in the TA 102 strain at dose-levels ≥ 50 μg/plate and in the remaining tester strains generally at dose-levels ≥ 25 μg/plate. - Remarks on result:
- other: all strains/cell types tested
Applicant's summary and conclusion
- Conclusions:
- In an Ames test performed according to OECD guideline and GLP principles (although no E.coli strain was included), NXL104 was found not to be mutagenic with or without metabolic activation when tested up to cytotoxic concentrations.
- Executive summary:
An AMES test was performed with NXL104 according to OECD guideline and GLP principles, although no E.coli strain was included. The test item was shown to induce cytotoxicity at 50 μg/plate and above in absence of S9 mix. In presence of S9-mix, a slight to marked cytotoxicity was noted in the TA 102 strain at dose-levels ≥ 50 μg/plate and in the remaining tester strains generally at dose-levels ≥ 25 μg/plate. Up to cytotoxic level, all bacterial strains (TA98, TA100, TA 1535, TA 1537 and TA 102) showed negative responses, i.e. no significant dose-related increase in the number of revertants with or without metabolic activation was seen. No precipitation of the test substance was observed at any dose level. The negative and strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
Based on the results of this study it is concluded that NXL104 is not mutagenic in the Salmonella typhimurium reverse mutation assay with or without metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.